Edition:
United States

Insider Trading: Athersys Inc (ATHX.OQ)

ATHX.OQ on NASDAQ Stock Exchange Capital Market

2.51USD
11:34am EDT
Change (% chg)

$0.04 (+1.62%)
Prev Close
$2.47
Open
$2.45
Day's High
$2.53
Day's Low
$2.43
Volume
100,972
Avg. Vol
159,902
52-wk High
$2.62
52-wk Low
$1.02

All Insider Trades
Trading Date Name Title Type Shares Traded Price
18 Sep 2017

Lehmann (William Jr)

President Sell 15,000 $2.38
17 Sep 2017

Harrington (John J)

Officer and Director Sell 5,000 $2.22
16 Sep 2017

Campbell (Laura K)

Officer Sell 5,018 $2.22
16 Sep 2017

Van Bokkelen (Gil)

Chief Executive Officer Sell 13,168 $2.22
16 Sep 2017

Lehmann (William Jr)

President Sell 8,668 $2.22
16 Sep 2017

Harrington (John J)

Officer and Director Sell 8,442 $2.22
14 Sep 2017

Harrington (John J)

Officer and Director Sell 10,000 $2.14
16 Jun 2017

Lehmann (William Jr)

President Sell 5,440 $1.42
16 Jun 2017

Van Bokkelen (Gil)

Chief Executive Officer Sell 8,475 $1.42
16 Jun 2017

Campbell (Laura K)

Officer Sell 3,305 $1.42
16 Jun 2017

Harrington (John J)

Officer and Director Sell 5,327 $1.42
15 Jun 2017

Harrington (John J)

Officer and Director Sell 18,000 $1.44
14 Jun 2017

Harrington (John J)

Officer and Director Sell 18,000 $1.47
6 Jun 2017

Harrington (John J)

Officer and Director Buy 149,392 $0.00
6 Jun 2017

Campbell (Laura K)

Officer Buy 82,000 $0.00
6 Jun 2017

Van Bokkelen (Gil)

Chief Executive Officer Buy 225,008 $0.00
6 Jun 2017

Lehmann (William Jr)

President Buy 154,800 $0.00
16 Mar 2017

Campbell (Laura K)

Officer Sell 3,610 $1.15
16 Mar 2017

Van Bokkelen (Gil)

Chief Executive Officer Sell 8,475 $1.15
16 Mar 2017

Harrington (John J)

Officer and Director Sell 5,294 $1.15
16 Mar 2017

Lehmann (William Jr)

President Sell 5,413 $1.15
31 Jan 2017

Campbell (Laura K)

Officer Buy 20,000 $1.01
31 Jan 2017

Davis (Jordan S)

Director Buy 18,645 $1.01
31 Jan 2017

Davis (Jordan S)

Director Buy 25,535 $1.01
31 Jan 2017

Davis (Jordan S)

Director Buy 203,320 $1.01

Institutional Holders

% Shares Owned: 26.22%
# of Holders: 108
Total Shares Held: 29,865,340
3 Mo. Net Change: 1,972,479
# New Positions: 15
# Closed Positions: 9
# Increased Positions: 50
# Reduced Positions: 28
# Net Buyers: 22

Officers & Directors

Name Age Since Current Position

Gil Bokkelen

54 2000 Chairman of the Board, Chief Executive Officer

William Lehmann

49 2006 President, Chief Operating Officer

John Harrington

47 2007 Executive Vice President, Chief Scientific Officer, Director

Robert Deans

63 2011 Executive Vice President - Regenerative Medicine

Laura Campbell

51 2006 Vice President - Finance

Lee Babiss

59 2013 Lead Independent Director

Ismail Kola

60 2010 Independent Director

Lorin Randall

70 2007 Independent Director

Jack Wyszomierski

61 2010 Independent Director